|
private:intensitytherapeutics
|
3220740
|
Dec 3rd, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Dec 3rd, 2020 10:59AM
|
Dec 3rd, 2020 10:59AM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Dec 2nd, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Dec 2nd, 2020 01:21PM
|
Dec 2nd, 2020 01:21PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Dec 1st, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Dec 1st, 2020 12:58PM
|
Dec 1st, 2020 12:58PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Nov 30th, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Nov 29th, 2020 07:03PM
|
Nov 30th, 2020 01:49PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Nov 28th, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Nov 28th, 2020 02:38PM
|
Nov 28th, 2020 02:38PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Nov 27th, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Nov 27th, 2020 11:03AM
|
Nov 27th, 2020 11:03AM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Nov 26th, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Nov 26th, 2020 12:02PM
|
Nov 26th, 2020 12:02PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Nov 25th, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Nov 25th, 2020 05:18PM
|
Nov 25th, 2020 05:18PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Nov 24th, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Nov 24th, 2020 12:30PM
|
Nov 24th, 2020 12:30PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|
|
private:intensitytherapeutics
|
3220740
|
Nov 23rd, 2020 12:00AM
|
Intensity Therapeutics, Inc.
|
338
|
10.00
|
Open
|
Pharmaceuticals
|
Nov 23rd, 2020 02:36PM
|
Nov 23rd, 2020 02:36PM
|
Intensity Therapeutics is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. We leverage our DfuseRxSM technology platform to create new drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Our lead product candidate, INT230-6, is currently being evaluated in a Phase 1/2 clinical study in patients with various types of advanced solid tumors. INT230-6 has the potential to induce an adaptive immune response that not only attacks the injected tumor, but also non-injected tumors and unseen micro-metastases.
Intensity is based in Westport, Connecticut. For more information, please visit www.intensitytherapeutics.com and follow us on Twitter @IntensityInc.
|
Open
|
Biopharmaceuticals, Pharmaceuticals, Interventional Radiology, Cancer immune therapy, Immunotherapy, Health and Medicine
|
Open
|
61 Wilton Road, 3rd Floor
|
Westport
|
CT
|
US
|
06880
|
|
Intensity Therapeutics
|
|
Health Care Equipment & Services
|